Principal Investigator

Deblina Sarkar
Assistant Professor at MIT
AT&T Career Development Chair Professor at MIT Media Arts and Sciences
Founder and Director of Nano-Cybernetic Biotrek research lab

Prof. Deblina Sarkar is a trans-disciplinary innovator, initially trained in electrical engineering and physics and then, has traversed the realm of biology, driven by curiosity and belief that truly disruptive technologies can immerge at the interface of diverse research arenas. Her inventions include, among others, a 6-atom thick channel quantum-mechanical transistor overcoming fundamental power limitations, an ultra-sensitive label-free biosensor and technology for nanoscale deciphering of biological building blocks of brain. Her PhD dissertation was honored as
one of the top 3 dissertations throughout USA and Canada in the field of Mathematics, Physical sciences and all departments of Engineering. She is the recipient of numerous other awards and recognitions, including the Lancaster Award, Technology Review’s one of the Top 10 Innovators Under 35 from India, NIH K99/R00 Pathway to Independence Award, IEEE Early Career Award in Nanotechnology (only awardee worldwide in 2022), Innovative Early Career Engineer by National Academy of Engineering, the NIH Director’s New Innovator Award with the highest and rarely achieved impact score, the MIND Prize, the Science News' 10 Scientists to Watch, the Distinguished Scientist Award (one of the 3 awardees nationwide), the Nanomaterials Young Investigator Award (one of the 3 awardees worldwide) and many more Continue Reading....

Administrative Assistant

Post Docs

Ray Lee
Ishaq N. Khan
Postdoctoral Associate, MIT Media Lab

Khan is a cancer biologist working with Prof. Deblina Sarkar on developing novel therapeutic strategies for tumors which are resistant to standard treatments. Prior joining NCB, he worked as a postdoctoral research associate at Texas A&M Health Science Center, on developing novel small molecule kinase inhibitors for breast cancer brain metastasis with Prof. Alyismail from Irma Lerma School of Pharmacy. Before joining Texas A&M University, Khan worked as an Assistant professor at Khyber Medical University, where he established the only national brain tumors biobank from 350+ patients, with comprehensive clinical data including radiological scans, histopathological reports, biochemical, and hematological profiles. As PI of the Precision Oncomedicine Lab (C3POL), Khan retrieved cancer tissues, blood, DNA, RNA, and generated primary cell cultures from wide range of adult and pediatric brain tumors’ patients including meningiomas, medulloblastomas, pituitary tumors, schwannomas, ependymoma, glioblastomas and other astrocytic tumors. In addition, he has also initiated primary cell lines from breast cancer and oral-squamous cell carcinoma patients. Khan was awarded doctorate fellowship by King Abdulaziz University, where his research was focused on the molecular analysis of pathogenesis, pleomorphism, drug resistant, cancer stem cells, and unique genetic signatures of meningiomas, which resulted in discovery of AGR2 as a novel marker for aggressive brain tumors. Khan completed his Master research degree from University of Sunderland and his bachelor’s degree from University of Peshawar.